South African Health Products Regulatory Authority (SAHPRA)
Public Entity · Social Services · reports to Department of Health (DoH)
The South African Health Products Regulatory Authority regulates health products in South Africa. It was established under the Medicines and Related Substances Act as amended, and replaced the Medicines Control Council in 2018.
It evaluates and registers medicines, medical devices, in vitro diagnostics, complementary medicines and radiation-emitting equipment, licenses manufacturers wholesalers and pharmacies, conducts inspections, and monitors the safety of products after they reach the market.
It also authorises clinical trials and regulates the control of radioactive and hazardous substances. Its registration decisions during the COVID-19 pandemic, including the emergency authorisation of vaccines, brought its work to wide public attention.
Audit record, 5 years
Financial highlights, 2024/25
- Total Revenue
- R503m
- Total Expenditure
- −R449m
- Total Assets
- R529m
- Total Liabilities
- R385m
Values in rand. Sparklines run oldest to newest and are scaled to each series, not to zero.
Leadership, 23 listed
- Chairperson
- Dr Thapelo Motshudi
- Deputy Chairperson
- Prof Glenda Gray
- Board Members
- Dr Tobeka Boltina Dr Chevon Clark Dr Johanna Gouws Dr Alfred Kgasi Prof Rajesh Mahabeer Mr Moses Moselekwa Mr Anthony Ngcezula Mr Nkosenhle Ngongoma Ms Mmatebogo Nkoenyane
- Chief Executive Officer
- Dr Boitumelo Semete-Makokotlela
- Chief Financial Officer
- Mr Regardt Gouws
- Chief Operations Officer
- Ms Christelna Reynecke
- Executive Committee
- Ms Tammy Gopal Adv Mpho Mphelo
- Senior Management
- Ms Dineo Lemao Mr Mqondisi Maphophe Ms Simphiwe Matsabe Ms Silverani Padayachee Ms Pratibha Sobrun
- Communications Officers
- Mr Rodgers Baloi Ms Nthabi Moloi
Description written for this directory from the entity’s own published sources: www.sahpra.org.za, www.gov.za